The goal of these experiments was to test the effectiveness of the siRNA-loaded nanoparticle in preventing metastases in a mouse with a heavy tumor burden and also to examine whether combination treatment with GAST siRNA and muKRAS siRNA NPs could be co-administered and enhance the efficacy. Here, GAST is linked to neoplasm.